Hindson Benjamin J.'s Form 4 filing
10x Genomics, Inc. (TXG) · filed May 25, 2023
- Accession no.
- 0001610717-23-000066
- Filed
- May 25, 2023
- Trade date
- May 23, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions. Open-market sales total $131.5K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hindson Benjamin J.CIK 0001786391 | Director, Officer (See Remarks) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 23, 2023 | Class A Common Stock | SSaleDisposed | −243 | $55.06 | −$13,379.58 | 286,381 | Direct | |
| May 23, 2023 | Class A Common Stock | SSaleDisposed | −619 | $55.06 | −$34,082.14 | 285,762 | Direct | |
| May 23, 2023 | Class A Common Stock | SSaleDisposed | −735 | $55.06 | −$40,469.1 | 285,027 | Direct | |
| May 23, 2023 | Class A Common Stock | SSaleDisposed | −791 | $55.06 | −$43,552.46 | 284,236 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
President and Chief Scientific Officer